Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner
Golo Ahlenstiel(National Institutes of Health), Barbara Rehermann(United States Department of Health and Human Services), Marc G. Ghany(National Institute of Diabetes and Digestive and Kidney Diseases), Christopher Koh(National Institutes of Health), T. Jake Liang(National Institutes of Health), Birgit Edlich(National Institutes of Health), Jordan J. Feld(University Health Network), Theo Heller(National Institutes of Health), Yaron Rotman(National Institute of Diabetes and Digestive and Kidney Diseases), Jay H. Hoofnagle(National Institutes of Health), Rachel Titerence(National Institutes of Health)
Cited by 271
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
|Hepatology|2008|3k
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k